GCF and serum myeloperoxidase and matrix metalloproteinase-13 levels in renal transplant patients
Articles > Article · 2010
Authors: Gülnur EMİNGİL, Beral AFACAN, Taina Tervahartiala, Hüseyin TÖZ, FATMA GÜL ATİLLA, Timo Sorsa
Archives of Oral Biology, Journal Indexed in SCI Expanded, International, WoS, 2010, vol 55, pp 719-727
DOI: 10.1016/j.archoralbio.2010.06.011
Summary
Aim: The rationale of this study was to address whether local or systemic changes reflect proteolytic (matrix metalloproteinase-13) or oxidative (myeloperoxidase) stress in renal transplant patients receiving cyclosporine-A (CsA) and having gingival overgrowth (GO), in patients receiving CsA therapy and having no GO and patients receiving tacrolimus therapy.